[
    "{\"step_by_step_thinking\": \"No, patients using inhaled glucocorticoids for asthma or COPD should not be advised to stop these medications to prevent COVID-19. Inhaled glucocorticoids are a mainstay of treatment for asthma and COPD, and abruptly stopping these medications can lead to worsening of symptoms and increased risk of exacerbations. There is currently no evidence to suggest that inhaled glucocorticoids increase the risk of COVID-19 infection or worsen outcomes in patients with COVID-19. In fact, there is some evidence to suggest that inhaled glucocorticoids may have a beneficial effect in reducing the risk of severe respiratory complications in patients with COVID-19. Therefore, it is important for patients to continue using their prescribed inhaled glucocorticoids as directed by their healthcare provider.\", \"answer_choice\": \"B\"}"
]